Long-term risk factors for occult cancer detection in patients with unprovoked venous thromboembolism: A post-hoc analysis of the REVERSE Study

被引：0
|
作者：
Cantor, Nathan [1 ,2 ]
Veillet-Lemay, Gabrielle [5 ]
Sabri, Elham [3 ]
Carrier, Marc [1 ]
Kovacs, Michael [4 ]
Rodger, Marc [1 ]
机构：
[1] Univ Ottawa, Dept Med, Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[2] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada
[3] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada
[4] Univ Western Ontario, Div Hematol, Dept Med, London, ON, Canada
[5] Univ Ottawa, Div Dermatol, Dept Med, Ottawa, ON, Canada
来源：
THROMBOSIS RESEARCH | 2018年 / 170卷
关键词：
D O I：
10.1016/j.thromres.2018.09.034
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
10
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [31] Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study
    Eischer, L.
    Kammer, M.
    Traby, L.
    Kyrle, P. A.
    Eichinger, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (07) : 1368 - 1374
  • [32] Edoxaban For Long-Term Treatment Of Venous Thromboembolism Cancer Patients
    Raskob, Gary E.
    Buller, Harry
    Angchaisuksiri, Pantep
    Oh, Doyeun
    Boda, Zoltan
    Lyons, Roger M.
    Weitz, Jeffrey I.
    Zhang, George
    Lanz, Hans J.
    Mercuri, Michele
    BLOOD, 2013, 122 (21)
  • [33] Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
    Akl, Elie A.
    Labedi, Nawman
    Barba, Maddalena
    Terrenato, Irene
    Sperati, Francesca
    Muti, Paola
    Schuenemann, Holger
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (06):
  • [34] Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
    Akl, Elie A.
    Kahale, Lara
    Barba, Maddalena
    Neumann, Ignacio
    Labedi, Nawman
    Terrenato, Irene
    Sperati, Francesca
    Muti, Paola
    Schuenemann, Holger
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (07):
  • [35] What is the long-term risk for new cancer in patients with a first episode of venous thromboembolism?
    Douketis, J.
    Gu, C.
    Piccioli, A.
    Ghirarduzzi, A.
    Pengo, V
    Prandoni, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 106 - 106
  • [36] Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis
    Khan, Faizan
    Rahman, Alvi
    Tritschler, Tobias
    Carrier, Marc
    Kearon, Clive
    Weitz, Jeffrey, I
    Schulman, Sam
    Couturaud, Francis
    Becattini, Cecilia
    Agnelli, Giancarlo
    Brighton, Timothy A.
    Lensing, Anthonie W. A.
    Pinede, Laurent
    Parpia, Sameer
    Geersing, Geert-Jan
    Takada, Toshihiko
    Bradbury, Charlotte A.
    Andreozzi, Giuseppe M.
    Palareti, Gualtiero
    Prandoni, Paolo
    Buller, Harry R.
    Mallick, Ranjeeta
    Hutton, Brian
    Thavorn, Kednapa
    Le Gal, Gregoire
    Rodger, Marc A.
    Fergusson, Dean A.
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (07) : 1186 - 1197
  • [37] Long-term incidence, risk factors and complications for venous thromboembolism in patients with systemic lupus erythematosus
    Nossent, Johannes Cornelis
    Keen, Helen Isobel
    Preen, David Brian
    Inderjeeth, Charles Anoukpar
    LUPUS, 2024, 33 (08) : 787 - 796
  • [38] Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study
    Noumegni, Steve Raoul
    Didier, Romain
    Mansourati, Vincent
    Tromeur, Cecile
    Le Moigne, Emmanuelle
    Hoffmann, Clement
    Nasr, Bahaa
    Gentric, Jean-Christophe
    Guegan, Marie
    Poulhazan, Elise
    Lacut, Karine
    Bressollette, Luc
    Le Mao, Raphael
    Couturaud, Francis
    THROMBOSIS RESEARCH, 2022, 214 : 93 - 105
  • [39] Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial
    Yee, Megan K.
    Nafee, Tarek
    Daaboul, Yazan
    Korjian, Serge
    AlKhalfan, Fahad
    Kerneis, Mathieu
    Wiest, Cara
    Goldhaber, Samuel Z.
    Hernandez, Adrian F.
    Hull, Russell D.
    Cohen, Alexander T.
    Harrington, Robert A.
    Gibson, C. Michael
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (01) : 1 - 8
  • [40] Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial
    Megan K. Yee
    Tarek Nafee
    Yazan Daaboul
    Serge Korjian
    Fahad AlKhalfan
    Mathieu Kerneis
    Cara Wiest
    Samuel Z. Goldhaber
    Adrian F. Hernandez
    Russell D. Hull
    Alexander T. Cohen
    Robert A. Harrington
    C. Michael Gibson
    Journal of Thrombosis and Thrombolysis, 2018, 45 : 1 - 8
12345